4trx: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The solution structure of recombinant human thioredoxin (105 residues) has, been determined by nuclear magnetic resonance (NMR) spectroscopy combined, with hybrid distance geometry-dynamical simulated annealing calculations., Approximate interproton distance restraints were derived from nuclear, Overhauser effect (NOE) measurements. In addition, a large number of, stereospecific assignments for beta-methylene protons and torsion angle, restraints for phi, psi, and chi 1 were obtained by using a conformational, grid search on the basis of the intraresidue and sequential NOE data in, conjunction with 3JHN alpha and 3J alpha beta coupling constants. The, structure calculations were based on 1983 approximate interproton distance, restraints, 52 hydrogen-bonding restraints for 26 hydrogen bonds, and 98, phi, 71 psi, and 72 chi 1 torsion angle restraints. The 33 final simulated, annealing structures obtained had an average atomic rms distribution of, the individual structures about the mean coordinate positions of 0.40 +/-, 0.06 A for the backbone atoms and 0.78 +/- 0.05 A for all atoms. The, solution structure of human thioredoxin consists of a five-stranded, beta-sheet surrounded by four alpha-helices, with an active site, protrusion containing the two redox-active cysteines. The overall, structure is similar to the crystal and NMR structures of oxidized [Katti, S. K., LeMaster, D. M., & Eklund, H. (1990) J. Mol. Biol. 212, 167-184], and reduced [Dyson, J. H., Gippert, G. P., Case, D. A., Holmgren, A., &, Wright, P. (1990) Biochemistry 29, 4129-4136] Escherichia coli, thioredoxin, respectively, despite the moderate 25% amino acid sequence, homology. Several differences, however, can be noted. The human alpha 1, helix is a full turn longer than the corresponding helix in E. coli, thioredoxin and is characterized by a more regular helical geometry. The, helix labeled alpha 3 in human thioredoxin has its counterpart in the, 3(10) helix of the E. coli protein and is also longer in the human, protein. In contrast to these structural differences, the conformation of, the active site loop in both proteins is very similar, reflecting the, perfect sequence identity for a stretch of eight amino acid residues, around the redox-active cysteines.
The solution structure of recombinant human thioredoxin (105 residues) has been determined by nuclear magnetic resonance (NMR) spectroscopy combined with hybrid distance geometry-dynamical simulated annealing calculations. Approximate interproton distance restraints were derived from nuclear Overhauser effect (NOE) measurements. In addition, a large number of stereospecific assignments for beta-methylene protons and torsion angle restraints for phi, psi, and chi 1 were obtained by using a conformational grid search on the basis of the intraresidue and sequential NOE data in conjunction with 3JHN alpha and 3J alpha beta coupling constants. The structure calculations were based on 1983 approximate interproton distance restraints, 52 hydrogen-bonding restraints for 26 hydrogen bonds, and 98 phi, 71 psi, and 72 chi 1 torsion angle restraints. The 33 final simulated annealing structures obtained had an average atomic rms distribution of the individual structures about the mean coordinate positions of 0.40 +/- 0.06 A for the backbone atoms and 0.78 +/- 0.05 A for all atoms. The solution structure of human thioredoxin consists of a five-stranded beta-sheet surrounded by four alpha-helices, with an active site protrusion containing the two redox-active cysteines. The overall structure is similar to the crystal and NMR structures of oxidized [Katti, S. K., LeMaster, D. M., & Eklund, H. (1990) J. Mol. Biol. 212, 167-184] and reduced [Dyson, J. H., Gippert, G. P., Case, D. A., Holmgren, A., & Wright, P. (1990) Biochemistry 29, 4129-4136] Escherichia coli thioredoxin, respectively, despite the moderate 25% amino acid sequence homology. Several differences, however, can be noted. The human alpha 1 helix is a full turn longer than the corresponding helix in E. coli thioredoxin and is characterized by a more regular helical geometry. The helix labeled alpha 3 in human thioredoxin has its counterpart in the 3(10) helix of the E. coli protein and is also longer in the human protein. In contrast to these structural differences, the conformation of the active site loop in both proteins is very similar, reflecting the perfect sequence identity for a stretch of eight amino acid residues around the redox-active cysteines.


==Disease==
==Disease==
Line 16: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Clore, G.M.]]
[[Category: Clore, G M.]]
[[Category: Forman-Kay, J.D.]]
[[Category: Forman-Kay, J D.]]
[[Category: Gronenborn, A.M.]]
[[Category: Gronenborn, A M.]]
[[Category: electron transport]]
[[Category: electron transport]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 17:45:38 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 19:14:36 2008''

Revision as of 20:14, 21 February 2008

File:4trx.jpg


4trx

Drag the structure with the mouse to rotate

HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF REDUCED RECOMBINANT HUMAN THIOREDOXIN IN SOLUTION

OverviewOverview

The solution structure of recombinant human thioredoxin (105 residues) has been determined by nuclear magnetic resonance (NMR) spectroscopy combined with hybrid distance geometry-dynamical simulated annealing calculations. Approximate interproton distance restraints were derived from nuclear Overhauser effect (NOE) measurements. In addition, a large number of stereospecific assignments for beta-methylene protons and torsion angle restraints for phi, psi, and chi 1 were obtained by using a conformational grid search on the basis of the intraresidue and sequential NOE data in conjunction with 3JHN alpha and 3J alpha beta coupling constants. The structure calculations were based on 1983 approximate interproton distance restraints, 52 hydrogen-bonding restraints for 26 hydrogen bonds, and 98 phi, 71 psi, and 72 chi 1 torsion angle restraints. The 33 final simulated annealing structures obtained had an average atomic rms distribution of the individual structures about the mean coordinate positions of 0.40 +/- 0.06 A for the backbone atoms and 0.78 +/- 0.05 A for all atoms. The solution structure of human thioredoxin consists of a five-stranded beta-sheet surrounded by four alpha-helices, with an active site protrusion containing the two redox-active cysteines. The overall structure is similar to the crystal and NMR structures of oxidized [Katti, S. K., LeMaster, D. M., & Eklund, H. (1990) J. Mol. Biol. 212, 167-184] and reduced [Dyson, J. H., Gippert, G. P., Case, D. A., Holmgren, A., & Wright, P. (1990) Biochemistry 29, 4129-4136] Escherichia coli thioredoxin, respectively, despite the moderate 25% amino acid sequence homology. Several differences, however, can be noted. The human alpha 1 helix is a full turn longer than the corresponding helix in E. coli thioredoxin and is characterized by a more regular helical geometry. The helix labeled alpha 3 in human thioredoxin has its counterpart in the 3(10) helix of the E. coli protein and is also longer in the human protein. In contrast to these structural differences, the conformation of the active site loop in both proteins is very similar, reflecting the perfect sequence identity for a stretch of eight amino acid residues around the redox-active cysteines.

DiseaseDisease

Known disease associated with this structure: Ciliary dyskinesia, primary, 6 OMIM:[607421]

About this StructureAbout this Structure

4TRX is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

High-resolution three-dimensional structure of reduced recombinant human thioredoxin in solution., Forman-Kay JD, Clore GM, Wingfield PT, Gronenborn AM, Biochemistry. 1991 Mar 12;30(10):2685-98. PMID:2001356

Page seeded by OCA on Thu Feb 21 19:14:36 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA